IVVD (STOCKS)
Invivyd, Inc. Common Stock
$1.760200
+0.000200 (+0.01%)
Prev close: $1.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William E. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $487.48M
- Employees
- 100
- P/E (TTM)
- -4.79
- P/B (TTM)
- 2.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $53.43M |
| Benefits Costs and Expenses | $105.92M |
| Costs And Expenses | $108.99M |
| Nonoperating Income/Loss | $3.07M |
| Operating Expenses | $108.99M |
| Selling, General, and Administrative Expenses | $66.93M |
| Research and Development | $38.31M |
| Other Operating Expenses | $3.75M |
| Operating Income/Loss | -$55.56M |
| Income/Loss From Continuing Operations After Tax | -$52.49M |
| Income/Loss From Continuing Operations Before Tax | -$52.49M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$52.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.30 |
| Diluted Earnings Per Share | -$0.30 |
| Basic Average Shares | 172,212,902 |
| Diluted Average Shares | 172,212,902 |
| Assets | $276.88M |
| Current Assets | $247.47M |
| Noncurrent Assets | $29.42M |
| Fixed Assets | $1.37M |
| Other Non-current Assets | $28.05M |
| Liabilities | $35.34M |
| Current Liabilities | $34.16M |
| Accounts Payable | $13.74M |
| Other Current Liabilities | $20.42M |
| Noncurrent Liabilities | $1.18M |
| Equity | $241.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $241.54M |
| Liabilities And Equity | $276.88M |
| Net Cash Flow From Operating Activities | -$58.14M |
| Net Cash Flow From Operating Activities, Continuing | -$58.14M |
| Net Cash Flow From Investing Activities | -$155.00K |
| Net Cash Flow From Investing Activities, Continuing | -$155.00K |
| Net Cash Flow From Financing Activities | $215.63M |
| Net Cash Flow From Financing Activities, Continuing | $215.63M |
| Net Cash Flow | $157.34M |
| Net Cash Flow, Continuing | $157.34M |
| Comprehensive Income/Loss | -$52.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.53M |
| Other Comprehensive Income/Loss | -$36.00K |